Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Production of proinflammatory cytokines contributes to cardiac dysfunction during ischemia-reperfusion. The principal mechanism responsible for the induction of this innate stress response during periods of myocardial ischemia-reperfusion remains unknown. Toll-like receptor 2 (TLR2) is a highly conserved pattern recognition receptor that has been implicated in the innate immune response to a variety of pathogens. However, TLR2 may also mediate inflammation in response to noninfectious injury. We therefore hypothesized that TLR2 is essential for modulating myocardial inflammation and left ventricular (LV) function during ischemia-reperfusion injury. Susceptibility to myocardial ischemia-reperfusion injury following ischemia-reperfusion was determined in Langendorff-perfused hearts isolated from wild-type mice and mice deficient in TLR2 (TLR2D) and Toll interleukin receptor domain-containing adaptor protein. After ischemia-reperfusion, contractile performance was significantly impaired in hearts from wild-type mice as demonstrated by a lower recovery of LV developed pressure relative to TLR2D hearts. Creatinine kinase levels were similar in both groups after reperfusion. Contractile dysfunction in wild-type hearts was associated with elevated cardiac levels of TNF and IL-1β. Ischemia-reperfusion-induced LV dysfunction was reversed by treatment with the recombinant TNF blocking protein etanercept. These studies show for the first time that TLR2 signaling importantly contributes to the LV dysfunction that occurs following ischemia-reperfusion. Thus disruption of TLR2-mediated signaling may be helpful to induce immediate or delayed myocardial protection from ischemia-reperfusion injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399 · cited 1×
“REPERFUSION OF BLOOD FLOW to ischemic myocardium is in and of itself associated with a distinct form of cardiac injury that is directly attributable to the toxic effects of reactive oxygen intermediates that are generated once the heart is reperfused (6, 7, 25).”
BackgroundToll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · cited 1×
“HMGB1 released by injured or necrotic cells has been shown to act as a signaling molecule, inducing local inflammatory responses (34).”
BackgroundNovel Signal Transduction Pathway Utilized by Extracellular HSP70
Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Baré, O., Auron, P. E., Stevenson, M. A., & Calderwood, S. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200497200 · Cited by 1,510
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042614 · Cited by 1,113
Self-citation
Cited by
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Tacar, O., Sriamornsak, P., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01567.x · Cited by 2,465
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Prabhu, S. D., & Frangogiannis, N. G. (2016) · Circulation Research · doi:10.1161/circresaha.116.303577 · Cited by 2,224
Linking oxidative stress to inflammation: Toll-like receptors
Gill, R., Tsung, A., & Billiar, T. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.006 · Cited by 553
“A reduction in collagen type 1 mRNA and reduced myocardial fibrosis in the non-infarct area accompanied by higher fractional shortening was found in TLR2 deficient mice subjected to warm I/R, and hearts from TLR2 deficient mice had higher left ventricular end diastolic pressures ex vivo [56, 62].”
BackgroundEndoplasmic Reticulum Stress As a Therapeutic Target in Cardiovascular Disease
Minamino, T., Komuro, I., & Kitakaze, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.227819 · Cited by 477
Role of Inflammation and Its Mediators in Acute Ischemic Stroke
Jin, R., Liu, L., Zhang, S., Nanda, A., & Li, G. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9508-6 · Cited by 418
The Emerging Role of Innate Immunity in the Heart and Vascular System: For Whom the Cell Tolls
Mann, D. L. (2011) · Circulation Research · doi:10.1161/circresaha.110.226936 · Cited by 365
Self-citationArslan, F., Smeets, M. B., O'Neill, L. A. J., Keogh, B., McGuirk, P., Timmers, L., Tersteeg, C., Hoefer, I. E., Doevendans, P. A., Pasterkamp, G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.880187 · Cited by 358
Innate immune signaling in cardiac ischemia
Arslan, F., de Kleijn, D. P., & Pasterkamp, G. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.38 · Cited by 347
TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY
Arumugam, T. V., Okun, E., Tang, S.-C., Thundyil, J., Taylor, S. M., & Woodruff, T. M. (2009) · Shock · doi:10.1097/shk.0b013e318193e333 · Cited by 300
The innate immune response in reperfused myocardium
Timmers, L., Pasterkamp, G., de Hoog, V. C., Arslan, F., Appelman, Y., & de Kleijn, D. P. V. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs018 · Cited by 291
Toll-like receptor signaling in endogenous neuroprotection and stroke
Marsh, B. J., Williams-Karnesky, R. L., & Stenzel-Poore, M. P. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.067 · Cited by 255
Mullick, A. E., Soldau, K., Kiosses, W. B., Bell, T. A., Tobias, P. S., & Curtiss, L. K. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071096 · Cited by 223
Tahover, E., Patil, Y. P., & Gabizon, A. A. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000182 · Cited by 160
Favre, J., Musette, P., Douin-Echinard, V., Laude, K., Henry, J.-P., Arnal, J.-F., Thuillez, C., & Richard, V. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.140723 · Cited by 159
TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice
Dasu, M. R., Thangappan, R. K., Bourgette, A., DiPietro, L. A., Isseroff, R., & Jialal, I. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.158 · Cited by 73
Metadata
- Authors
- Sakata, Y., Dong, J.-W., Vallejo, J. G., Huang, C.-H., Baker, J. S., Tracey, K. J., Tacheuchi, O., Akira, S., & Mann, D. L.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2007-01
- Volume
- 292
- Issue
- 1
- Pages
- H503-H509
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2031309074
- Cited by
- 119
- References
- 5
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.